Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials - Challenges and future perspectives. A critical review.
Minelli A, Barlati S, Baune BT; European College of Neuropsychopharmacology (ECNP) Pharmacogenomics & Transcriptomics Network. Minelli A, et al. Among authors: barlati s. Eur Neuropsychopharmacol. 2022 Jun;59:68-81. doi: 10.1016/j.euroneuro.2022.04.007. Epub 2022 May 10. Eur Neuropsychopharmacol. 2022. PMID: 35561539 Review.
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates.
Vita A, Minelli A, Barlati S, Deste G, Giacopuzzi E, Valsecchi P, Turrina C, Gennarelli M. Vita A, et al. Among authors: barlati s. Front Pharmacol. 2019 Apr 16;10:402. doi: 10.3389/fphar.2019.00402. eCollection 2019. Front Pharmacol. 2019. PMID: 31040787 Free PMC article. Review.
The impact of the Covid-19 pandemic on patients with schizophrenia.
Vita A, Barlati S. Vita A, et al. Among authors: barlati s. Eur Neuropsychopharmacol. 2022 Jan;54:62-64. doi: 10.1016/j.euroneuro.2021.08.003. Epub 2021 Aug 14. Eur Neuropsychopharmacol. 2022. PMID: 34462180 Free PMC article. No abstract available.
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial).
Minelli A, Barlati S, Vitali E, Bignotti S, Dattilo V, Tura GB, Maffioletti E, Giacopuzzi E, Santoro V, Perusi G, Cobelli C, Magri C, Bonizzato S, Bocchio-Chiavetto L, Spina E, Vita A, Gennarelli M. Minelli A, et al. Among authors: barlati s. Trials. 2021 Dec 11;22(1):896. doi: 10.1186/s13063-021-05775-8. Trials. 2021. PMID: 34895291 Free PMC article. Clinical Trial.
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.
Chiappini S, d'Andrea G, De Filippis S, Di Nicola M, Andriola I, Bassetti R, Barlati S, Pettorruso M, Sensi S, Clerici M, Dell'Osso B, Vita A, Martinotti G. Chiappini S, et al. Among authors: barlati s. Eur Neuropsychopharmacol. 2023 Sep;74:15-21. doi: 10.1016/j.euroneuro.2023.04.011. Epub 2023 May 4. Eur Neuropsychopharmacol. 2023. PMID: 37148637 Free article.
292 results